banner
GLENMARK.NS image

Glenmark Pharmaceuticals Limited

GLENMARK.NS

1441

INR
+23.60
(+1.67%)
Day's range
1407.1
1449.7
52 wk Range
985.2
1830.95

GLENMARK.NS Income Statement

Period EndingMar 31, 2004Mar 31, 2005Mar 31, 2006Mar 31, 2007Mar 31, 2008Mar 31, 2009Mar 31, 2010Mar 31, 2011Mar 31, 2012Mar 31, 2013Mar 31, 2014Mar 31, 2015Mar 31, 2016Mar 31, 2017Mar 31, 2018Mar 31, 2019Mar 31, 2020Mar 31, 2021Mar 31, 2022Mar 31, 2023Mar 31, 2024
Total Revenue3,806,606,0006,120,532,0007,575,892,00012,515,336,00020,092,005,00021,160,332,00025,006,466,00029,490,700,00040,206,430,00049,691,420,00059,236,050,00065,215,790,00075,030,060,00088,638,190,00089,435,810,00097,050,840,000106,572,620,000108,060,260,000121,741,980,000115,832,350,000118,130,970,000
Cost of Revenue1,793,191,0002,714,675,0003,817,334,0004,574,712,0006,757,996,0008,750,997,00010,193,390,0009,918,320,00013,453,970,00025,688,490,00021,378,800,00019,434,520,00023,080,530,00026,191,280,00034,145,520,00037,640,350,00071,155,060,00072,257,320,00080,654,640,00079,530,400,00085,538,170,000
Gross Profit2,013,415,0003,405,857,0003,758,558,0007,940,624,00013,334,009,00012,409,335,00014,813,076,00019,572,380,00026,752,460,00024,002,930,00037,857,250,00045,781,270,00051,949,530,00062,446,910,00055,290,290,00059,410,490,00035,417,560,00035,802,940,00041,087,340,00036,301,950,00032,592,800,000
Gross Profit Margin0.5290.5560.4960.6340.6640.5860.5920.6640.6650.4830.6390.7020.6920.7050.6180.6120.3320.3310.3370.3130.276
R&D Expenses248,073,000326,512,000263,344,000432,609,000757,730,000882,703,000772,758,000004,115,590,0005,998,060,0006,014,420,0008,175,900,00012,622,330,00012,251,330,00014,480,260,00013,205,120,00013,186,910,00012,787,080,00012,500,350,00012,258,290,000
General & Administrative Expenses0-14,678,0000006,976,794,0007,844,662,00000966,020,000921,040,0001,590,190,0001,932,300,0002,222,520,0002,070,270,0002,753,920,0003,650,650,0003,172,640,0004,006,960,0003,039,990,0002,631,090,000
Selling & Marketing Expenses1,074,266,0001,521,825,0002,123,161,0003,245,159,0004,571,018,00000003,786,130,0003,645,160,0004,648,350,0006,580,920,0008,425,270,0007,628,870,0008,709,420,0007,038,540,0009,432,140,0008,963,070,00011,371,960,00010,922,730,000
SG&A Expenses1,074,266,0001,507,147,0002,123,161,0003,245,159,0004,571,018,0006,976,794,0007,844,662,0000011,489,550,00019,409,290,00015,453,600,0008,513,220,00010,647,790,0009,699,140,00028,737,780,00010,689,190,0006,099,390,00010,505,970,00014,320,440,00013,553,820,000
Other Expenses176,846,000299,256,000251,337,000649,673,000890,273,000-713,289,000716,469,00013,191,270,00020,495,000,00003,875,090,00016,828,180,00013,496,430,00013,585,150,0000293,780,000-197,410,000468,650,000-277,440,00000
Total Operating Expenses1,499,185,0002,132,915,0002,637,842,0004,327,441,0006,219,021,0007,146,208,0009,333,889,00013,191,270,00020,495,000,00021,991,890,00029,282,440,00038,296,200,00036,221,030,00047,437,450,00041,856,030,00043,511,820,00041,831,750,00019,672,970,00023,570,490,00025,289,180,00046,952,560,000
Total Costs & Expenses3,292,376,0004,847,590,0006,455,176,0008,902,153,00012,977,017,00015,897,205,00019,527,279,00023,109,760,00033,948,970,00040,808,730,00050,661,240,00057,385,770,00063,549,980,00073,844,180,00076,001,550,00081,152,170,00093,306,940,00091,930,290,000104,225,130,000104,819,580,00092,741,600,000
Interest Income08,419,00034,476,00014,182,00078,737,0000038,970,00089,120,00042,620,00066,440,00014,310,00075,800,000180,690,00089,360,00027,000,00046,760,00026,470,00094,350,00070,000,00061,760,000
Interest Expense100,578,000172,631,000181,672,000398,258,000710,417,0001,404,766,0001,640,213,0001,604,550,0001,465,670,0001,600,110,0001,885,940,0001,901,500,0001,788,850,0002,373,180,0002,855,670,0003,345,850,0003,773,180,0003,531,130,0002,980,990,0003,490,360,0005,159,690,000
Depreciation & Amortization110,930,000164,232,000232,344,000422,589,000716,795,0001,026,827,0001,206,104,000946,780,000978,780,0001,270,090,0002,167,950,0002,599,800,0002,691,420,0005,765,200,0003,540,670,0003,259,050,0004,171,660,0004,435,540,0004,867,150,0006,112,680,0005,819,060,000
EBITDA725,738,0001,601,386,0001,510,236,0004,419,848,0008,464,851,0005,120,406,0006,685,291,0007,366,690,0007,325,360,00010,207,350,00011,022,650,00010,444,130,00014,471,610,00020,739,900,00017,064,290,00019,611,190,00018,905,600,00021,791,420,00022,260,600,00011,580,520,00011,343,700,000
EBITDA Margin0.1910.2620.1990.3530.4210.2420.2670.250.1820.2050.1860.160.1930.2340.1910.2020.1770.2020.1830.10.096
Operating Income514,230,0001,272,942,0001,120,716,0003,613,183,0007,114,988,0005,263,127,0005,479,187,0006,380,940,0006,257,460,0008,894,640,0008,788,260,0007,830,020,00011,760,500,00014,794,010,00013,434,260,00015,898,670,00012,820,890,00017,160,360,00018,400,480,00010,788,740,0006,310,730,000
Operating Income Margin0.1350.2080.1480.2890.3540.2490.2190.2160.1560.1790.1480.120.1570.1670.150.1640.120.1590.1510.0930.053
Total Other Income/Expenses (Net)00000-2,574,314,000-1,640,213,000-1,565,580,000-1,376,550,000-1,504,590,000-1,819,500,000-1,887,190,000-1,713,050,000-2,192,490,000-2,766,310,000-2,892,380,000-1,860,130,000-3,335,610,000-3,988,020,000-8,390,320,000-5,945,780,000
Income Before Tax514,230,0001,272,942,0001,120,716,0003,613,183,0007,114,988,0002,688,813,0003,838,974,0004,815,360,0004,880,910,0007,390,050,0006,968,760,0005,942,830,00010,047,450,00012,601,520,00010,667,950,00013,006,290,00010,960,760,00013,824,750,00014,412,460,0002,398,420,000364,950,000
Pre-Tax Income Margin0.1350.2080.1480.2890.3540.1270.1540.1630.1210.1490.1180.0910.1340.1420.1190.1340.1030.1280.1180.0210.003
Income Tax Expense100,889,000201,531,000240,956,000512,583,000793,865,000754,084,000528,658,000237,200,000237,840,0001,107,150,0001,512,730,0001,190,430,0003,028,400,0003,442,310,0002,925,120,0003,756,360,0003,201,060,0004,123,870,0004,475,970,0003,294,030,00018,673,450,000
Net Income413,606,0001,071,146,000879,760,0003,100,600,0006,321,327,0001,934,729,0003,310,316,0004,578,330,0004,603,480,0006,200,330,0005,422,750,0004,753,100,0007,020,980,0009,159,670,0007,741,910,0009,249,930,0007,759,700,0009,700,380,0009,417,110,0002,972,450,000-15,016,680,000
Net Income Margin0.1090.1750.1160.2480.3150.0910.1320.1550.1140.1250.0920.0730.0940.1030.0870.0950.0730.090.0770.026-0.127
Earnings Per Share (EPS)1.764.493.6412.9925.87.712.416.7817.0322.9120.0117.5225.0132.4627.4432.7827.534.3833.3710.53-53.22
Diluted Earnings Per Share (EPS)1.754.083.2111.5624.97.512.416.7617.0122.892017.522532.4527.4332.7827.534.3833.3710.53-53.22
Weighted Average Shares Outstanding228,714,000237,162,000237,332,000238,116,000244,619,000250,025,000260,759,000270,041,025270,383,075270,688,485271,028,503271,263,190280,727,485282,166,682282,168,156282,168,156282,168,156282,168,156282,168,156282,168,156282,162,345
Weighted Average Shares Outstanding (Diluted)229,810,000260,800,000269,612,000267,558,000253,240,000255,262,000261,324,000270,458,814270,640,216270,880,872271,153,337271,357,683280,786,476282,251,976282,205,201282,178,396282,168,156282,168,156282,168,156282,168,156282,178,746